We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug News
    • Trending
    • Commercial Operations
    • GMPs, Inspections and Audits
    • Postmarket Safety
    • Quality
    • Regulatory Affairs
    • Research and Development
    • Submissions and Approvals
    • FDAnews Drug Daily Bulletin
    • Drug Industry Daily
  • Device News
    • Trending
    • Commercial Operations
    • Inspections and Audits
    • Postmarket Safety
    • Quality
    • Regulatory Affairs
    • Research and Development
    • Submissions and Approvals
    • FDAnews Device Daily Bulletin
    • FDAnews Device Daily Bulletin Premium
  • Books
    • FDAnews Books Library
    • Drug Books
    • Device Books
  • Training/Events
    • Webinar Training Pass
    • Events
  • Resources
    • Form 483s Database
    • FDA Approved Drugs
    • eCFR and Guidances
    • White Papers
  • CenterWatch
  • About Us
    • The Company
    • Contact Us
  • Advertising
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Store » Drug Books » Supplier Management for Drugmakers: Qualification, Contracts and Audits

Other Options

PDF Edition

$397.00

PDF Edition - 3-4 Copies (10% Off)

$357.00

PDF Edition - 5-6 Copies (15% Off)

$337.00

PDF Edition - 7-9 Copies (20% Off)

$317.00

PDF Edition - 10+ Copies (25% Off)

$297.00
Supplier-Management-for-Drugmakers-500.jpg

Supplier Management for Drugmakers: Qualification, Contracts and Audits

$397.00
Drug Books

Product Details

As a successful drugmaker, you know there’s no passing the buck to suppliers and vendors when it comes to meeting regulatory requirements.

You must choose suppliers wisely and exercise careful oversight. The expert contributors to Supplier Management for Drugmakers will enable you to do just that. They share how to pick the highest-quality and most reliable firms and how to hammer out a contract that will hold the supplier to your standards.

Supplier Management for Drugmakers covers the three phases of working with suppliers and vendors:

  • Qualification section — you’ll understand how to evaluate prospects and score them on the most important factors, including communication, compliance, facilities, logistics and price.
  • Contracts section — you’ll know the 24 elements to cover in any supplier agreement, including technical transfer, change control, deviation handling, complaint management, quality review and records retention.
  • Supplier auditing section — your four-part plan will enable you to decide the who, what, when and how of overseeing your contractors, including conducting for-cause audits, qualities of an effective auditor and how to write effective audit observations.

Supplier Management for Drugmakers: Qualification, Contracts and Audits will help you maintain quality and improve compliance in upgrading your supplier management skills by:

  • Understanding core competency areas on which to evaluate suppliers
  • Determining what constitutes due diligence in researching suppliers
  • Scoring and comparing suppliers
  • Creating a certified supplier list
  • Ascertaining how much advance notice of an audit to give a supplier
  • Developing a risk-assessment methodology
  • Recognizing the differences among system audits, procedure/process audits and product audits
  • Knowing when and how to conduct a remote audit.

Bonus: Supplier Management for Drugmakers contains copies of FDA and ICH guidances and hands-on tools for managing your supplier-related responsibilities.

Enhance your supplier management skills and pick the right supplier, craft the best contract and perform audits with Supplier Management for Drugmakers: Qualification, Contracts and Audits. Order your copy today.

About the Contributors

This report was contributed to by various supplier management experts, including:

Steven Sharf is a Principal at GMP Concepts. He has worked for several pharmaceutical companies in quality roles, including Merck, Boehringer Ingelheim, Schering-Plough and Novartis. 

John Avellanet, managing director and principal of Cerulean Associates, is a former device and biopharma executive. Today he is an internationally acknowledged expert, speaker and syndicated author on cost-effective FDA compliance.

Who Will Benefit

  • Quality unit professionals
  • Vendor relations personnel
  • Legal personnel
  • Regulatory professionals

PDF

$397.00
Add to Cart

Contributors:
Steven Sharf and John Avellanet

ISBN-13:
978-1-60430-146-5

Publication date:
Aug. 2020

Page count:
181


Multi-user Access
Save money with a license agreement allowing significant numbers of users access to an electronic version of this book. For multi-user access to multiple titles, FDAnews offers the FDAnews Books Library — a personalized collection of FDAnews publications that is fully searchable. Contact Customer Service for a quote or more information.


Our Guarantee
Not satisfied with your publication? For the PDF version, you must notify FDAnews within 24 hours of receipt of purchase and we will refund 100 percent of your purchase price.

  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell or Share My Data
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing